Conventional fractionation should not be the standard of care for T2 glottic cancer

BACKGROUND: The aim of this study was to report outcomes and late toxicity following hypofractionated accelerated radiotherapy for T2 glottic cancers. We highlight the importance of hypofractionated treatments with shorter overall treatment times, in improving outcomes for T2 glottic cancers. We als...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol
Hlavní autoři: Dixon, Lynne M., Douglas, Catriona M., Shaukat, Shazril Imran, Garcez, Kate, Lee, Lip Wai, Sykes, Andrew J., Thomson, David, Slevin, Nicholas J.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686811/
https://ncbi.nlm.nih.gov/pubmed/29137654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0915-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky